Meet our doctors Last reviewed: 19 Jun 2026 Sources Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Transdermal drug delivery: overcoming the skin's barrier function, Europe PMC [accessed 14 January 2026] (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteins, Advanced Drug Delivery Reviews, [accessed 14 January 2026] Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism, [accessed 14 January 2026] Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK, [accessed 14 January 2026]
Coverage for any of these still requires PA with documentation matching the specific indication
For example, the heart and kidneys have a complex and interconnected relationship
By conducting direct comparisons of patients experiences when switching GLP-1 RAs, more detailed information can be derived to support treatment choices in clinical practice
OTC digestive products should be used as directed on the product label
For Further Information Regarding this Report: Request a Free Sample Type 2 diabetes and obesity are major health issues that affect a large number of people worldwide